These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 26308525)
1. Baseline Plasma C-Reactive Protein Concentrations and Motor Prognosis in Parkinson Disease. Umemura A; Oeda T; Yamamoto K; Tomita S; Kohsaka M; Park K; Sugiyama H; Sawada H PLoS One; 2015; 10(8):e0136722. PubMed ID: 26308525 [TBL] [Abstract][Full Text] [Related]
2. Baseline C-Reactive Protein Levels and Life Prognosis in Parkinson Disease. Sawada H; Oeda T; Umemura A; Tomita S; Kohsaka M; Park K; Yamamoto K; Sugiyama H PLoS One; 2015; 10(7):e0134118. PubMed ID: 26218286 [TBL] [Abstract][Full Text] [Related]
3. Blood NfL: A biomarker for disease severity and progression in Parkinson disease. Lin CH; Li CH; Yang KC; Lin FJ; Wu CC; Chieh JJ; Chiu MJ Neurology; 2019 Sep; 93(11):e1104-e1111. PubMed ID: 31420461 [TBL] [Abstract][Full Text] [Related]
4. Subclinical elevation of plasma C-reactive protein and illusions/hallucinations in subjects with Parkinson's disease: case-control study. Sawada H; Oeda T; Umemura A; Tomita S; Hayashi R; Kohsaka M; Yamamoto K; Sudoh S; Sugiyama H PLoS One; 2014; 9(1):e85886. PubMed ID: 24497930 [TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal Fluid C-Reactive Protein in Parkinson's Disease: Associations with Motor and Non-motor Symptoms. Sanjari Moghaddam H; Valitabar Z; Ashraf-Ganjouei A; Mojtahed Zadeh M; Ghazi Sherbaf F; Aarabi MH Neuromolecular Med; 2018 Sep; 20(3):376-385. PubMed ID: 29980980 [TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid inflammatory markers in Parkinson's disease--associations with depression, fatigue, and cognitive impairment. Lindqvist D; Hall S; Surova Y; Nielsen HM; Janelidze S; Brundin L; Hansson O Brain Behav Immun; 2013 Oct; 33():183-9. PubMed ID: 23911592 [TBL] [Abstract][Full Text] [Related]
7. Actigraphy monitoring of symptoms in patients with Parkinson's disease. Pan W; Kwak S; Li F; Wu C; Chen Y; Yamamoto Y; Cai D Physiol Behav; 2013 Jul; 119():156-60. PubMed ID: 23748129 [TBL] [Abstract][Full Text] [Related]
8. Predicting outcomes in Parkinson's disease: comparison of simple motor performance measures and The Unified Parkinson's Disease Rating Scale-III. Grill S; Weuve J; Weisskopf MG J Parkinsons Dis; 2011; 1(3):287-98. PubMed ID: 23939309 [TBL] [Abstract][Full Text] [Related]
9. Metabolomic biomarkers as strong correlates of Parkinson disease progression. LeWitt PA; Li J; Lu M; Guo L; Auinger P; Neurology; 2017 Feb; 88(9):862-869. PubMed ID: 28179471 [TBL] [Abstract][Full Text] [Related]
10. Blood biomarkers with Parkinson's disease clusters and prognosis: The oxford discovery cohort. Lawton M; Baig F; Toulson G; Morovat A; Evetts SG; Ben-Shlomo Y; Hu MT Mov Disord; 2020 Feb; 35(2):279-287. PubMed ID: 31693246 [TBL] [Abstract][Full Text] [Related]
11. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213 [TBL] [Abstract][Full Text] [Related]
12. Influence of depression in mild Parkinson's disease on longitudinal motor and cognitive function. Ng A; Chander RJ; Tan LC; Kandiah N Parkinsonism Relat Disord; 2015 Sep; 21(9):1056-60. PubMed ID: 26117438 [TBL] [Abstract][Full Text] [Related]
13. Is there an association between the level of high-sensitivity C-reactive protein and idiopathic Parkinson's disease? A comparison of Parkinson's disease patients, disease controls and healthy individuals. Song IU; Kim JS; Chung SW; Lee KS Eur Neurol; 2009; 62(2):99-104. PubMed ID: 19521085 [TBL] [Abstract][Full Text] [Related]
14. Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1. Wills AM; Pérez A; Wang J; Su X; Morgan J; Rajan SS; Leehey MA; Pontone GM; Chou KL; Umeh C; Mari Z; Boyd J; JAMA Neurol; 2016 Mar; 73(3):321-8. PubMed ID: 26751506 [TBL] [Abstract][Full Text] [Related]
15. Is neuroinflammation involved in the development of dementia in patients with Parkinson's disease? Song IU; Kim YD; Cho HJ; Chung SW Intern Med; 2013; 52(16):1787-92. PubMed ID: 23955613 [TBL] [Abstract][Full Text] [Related]
16. Clinical evolution of Parkinson's disease and prognostic factors affecting motor progression: 9-year follow-up study. Reinoso G; Allen JC; Au WL; Seah SH; Tay KY; Tan LC Eur J Neurol; 2015 Mar; 22(3):457-63. PubMed ID: 24888502 [TBL] [Abstract][Full Text] [Related]
17. Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease. Kleiner-Fisman G; Fisman DN; Sime E; Saint-Cyr JA; Lozano AM; Lang AE J Neurosurg; 2003 Sep; 99(3):489-95. PubMed ID: 12959435 [TBL] [Abstract][Full Text] [Related]
18. Plasma oxidative and inflammatory markers in patients with idiopathic Parkinson's disease. Andican G; Konukoglu D; Bozluolcay M; Bayülkem K; Firtiına S; Burcak G Acta Neurol Belg; 2012 Jun; 112(2):155-9. PubMed ID: 22426659 [TBL] [Abstract][Full Text] [Related]